TEVA PHARMA IND.

Inactive Instrument

Highlights Teva Pharma Ind. Nyse

Equities

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cigna to offer Humira rivals with $0 copay at specialty pharmacy	Apr. 25	RE
Teva Pharm profit handily beats Q4 estimates, sales jump	Jan. 31	RE
Endo International : Drugmakers, pharmacies next targets for U.S. opioid settlements	21-07-21	RE
Endo International : J&J, other drugmakers go to trial in California in $50 billion case over 'deadly legacy' of opioids	21-04-19	RE
Exclusive: AbbVie in talks to sell $5 billion women's drugs portfolio - sources	21-03-15	RE
Teva Pharmaceutical Industries : EU fines Teva, Cephalon over pay-for-delay drug deal	20-11-26	RE
U.S. court voids $448 million award against AbbVie, but revives FTC claim over AndroGel	20-09-30	RE
Glenmark Pharmaceuticals : U.S. charges Teva in generic drugs price-fixing probe	20-08-26	RE
Teva Pharmaceutical Industries : U.S. Unit Indicted on Price-Fixing Charges -- 4th Update	20-08-25	DJ
Teva Pharmaceutical Industries : U.S. Unit Indicted on Price-Fixing Charges -- 3rd Update	20-08-25	DJ
Teva Pharmaceutical Industries : U.S. Unit Indicted on Price-Fixing Charges -- 2nd Update	20-08-25	DJ
Teva Pharmaceutical Industries : U.S. Unit Indicted on Price-Fixing Charges -- Update	20-08-25	DJ
Teva Pharmaceutical Industries : U.S. Unit Indicted on Price-Fixing Charges	20-08-25	DJ
Teva Pharmaceutical Industries : U.S. Unit Accused of Using Donations to Aid Drug Business	20-08-19	DJ
Endo International : Mylan tightens revenue estimates on COVID-19 pressure; shares fall	20-08-06	RE
Regeneron Pharmaceuticals : Teva Pharm second-quarter profit tops forecast, reaffirms 2020 outlook	20-08-05	RE
Regeneron Pharmaceuticals : Teva Pharm second-quarter profit tops forecast, reaffirms 2020 outlook	20-08-05	RE
GLOBAL MARKETS LIVE: EssilorLuxottica, Nissan, Euronext, Uber…	19-05-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer